CLINICAL_TRIALS
research
· 2017-08-04
Clinical Trial Update: Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma [Phase 1]
Summary
Phase 1 clinical trial update examining disease pathology and key therapeutic targets in severe asthma; the study has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: TERMINATED